Table 1 Sociodemographic and clinical characteristics of the study participants in Northeast Ethiopia (2022–2023).

From: Molecular epidemiology, distribution, and determinants of cutaneous leishmaniasis in Northeast Ethiopia

Characteristics

Categories

Total, n(%)

LCL

ML

LR

MCL

Age,

< 9 years

40 (11.2)

27 (67.5)

12 (30)

0

1 (2.5)

9 to 19 years

173 (48.6)

129 (74.6)

31 (17.9)

1 (0.6)

12 (6.9)

> 19 years

143 (40.2)

111 (77.6)

25 (17.5)

1 (0.7)

6 (4.2)

Gender

Male

203 (57.0)

143 (70.4)

45 (22.2)

1 (0.5)

14 (6.9)

Female

153 (43.0)

124 (81.0)

23 (15.0)

1 (0.7)

5 (3.3)

Residence

Rural

280 (78.6)

205 (73.2)

60(21.4)

1(0.4)

14(5.0)

Urban

76 (21.4)

62 (81.6)

8 (10.5)

1 (1.3)

5 (6.6)

Educational status

Unable to read and write

93 (26.1)

65 (69.9)

22 (23.7)

0 (0.0)

6 (6.5)

Read and write

52 (14.5)

42 (80.8)

5 (9.6)

0 (0.0)

5 (9.6)

Primary

105 (29.4)

80 (76.2)

20 (19.0)

1 (1.0)

4 (3.8)

Secondary

79 (22.9)

61 (77.2)

15 (19.0)

1 (1.3)

2 (2.5)

Tertiary

27 (7.5)

19 (70.4)

6 (22.2)

0 (0.0)

2 (7.4)

Family size

< 5

215 (60.4)

162 (75.3)

41 (19.1)

2 (0.9)

10 (4.7)

> 5

141 (39.6)

105 (74.5)

27 (19.1)

0 (0.0)

9 (6.4)

Duration of the oldest lesion

less than three months

53 (14.9)

37 (69.8)

14 (26.4)

0 (0.0)

2 (3.8)

Three to six months

51 (14.3)

38 (74.1)

12 (23.5)

0 (0.0)

1 (2.0)

Seven months to 1 year

144 (40.4)

113 (78.5)

22 (15.3)

0 (0.0)

9 (6.2)

One year and above

108 (30.3)

79 (73.1)

20 (18.5)

2 (1.9)

7 (6.5)

Number of lesions

1

263 (73.9)

202 (76.8)

58 (22.1)

0 (0.0)

3 (1.1)

2

61 (17.1)

44 (72.1)

9 (14.8)

0 (0.0)

8 (12.1)

3

24 (6.7)

15 (62.5)

1 (4.2)

1 (4.2)

7 (29.2)

>=4

8 (2.2)

6 (75.0)

0

1 (12.5)

1 (12.5)

Location of the lesion

Face

269 (75.6)

266 (98.9)

0

1 (0.4)

2 (0.7)

Limbs/Neck/Trunk

2 (0.6)

1 (50.0)

0

1 (50.0)

0

Mucosal

68 (19.1)

0

68 (100)

0

0

Multiple

17 (4.8)

0

0

0

17 (89.5)

Presentation index of the lesion

crusted/scaly

122 (34.3)

110 (90.2)

9 (7.4)

0

3 (2.5)

Maculopapular

27 (7.7.6)

21 (77.8)

4 (14.8)

0

2 (7.4)

Nodular

16 (4.4.5)

13 (81.3)

2 (12.5)

0

1 (6.2)

Plaque

24 (6.7)

22 (91.7)

2 (8.3)

0

0

Swollen/Erythema

121 (34.0)

89 (73.6)

24 (19.8)

1 (0.8)

7 (5.8)

Ulcered

46 (12.9)

12 (26.1)

27 58. 7)

1 (2.2)

6 (13.0)

  1. LCL localized cutaneous leishmaniasis, MCL mucocutaneous leishmaniasis, ML mucosal leishmaniasis, DCL diffuse CL, IM intramuscular, LR leishmaniasis recidivan, IQR interquartile range.